Turn your clinical practice into published evidence.
Celéri gives interventional pain physicians and neuromodulation specialists the infrastructure to run IRB-compliant, publication-ready studies directly from their practice — without a dedicated research staff, without leaving clinical workflow, and without waiting years for academic collaboration to move.
Everything you need to run a research-grade practice.
From your first PRO to your first publication — Celéri provides the platform, the protocol infrastructure, and the partner network so you can focus on the science, not the administration.
Practice-Level Registry
Every patient encounter becomes a structured data point. PainIntel captures PROs automatically across your procedure types — building a longitudinal registry you own, searchable by diagnosis, procedure, payer, or outcome.
IRB-Ready Protocol Infrastructure
Celéri's master IRB protocols and pre-specified study designs reduce your time-to-activation. Move from concept to enrollment in weeks, not quarters. IRB submission support available through the Celéri Research Group.
AI-Assisted Patient Recruitment
PatientFinder™ identifies candidates for studies and advanced therapies within your existing patient panel — matching on diagnosis, procedure history, and clinical criteria. Automated outreach included.
Publication-Ready Data Governance
21 CFR Part 11-compatible audit trails, pre-specified PRO instruments, timestamped longitudinal data, and de-identification infrastructure — so your dataset is credible when you submit to NANS, ISMCS, or a peer-reviewed journal.
CPT 96127 Reimbursement
Practices may file medically necessary claims under CPT 96127 for PRO assessments gathered through PainIntel. Research activity offsets your platform costs. Practices that also participate in sponsored multicenter registries may receive additional FMV compensation from the sponsoring organization.
Research Group Partner Access
The Celéri Research Group connects you with best-in-class CRO, biostatistics, EDC, regulatory, and medical writing partners — scoped to your study. You contract only what you need. Celéri coordinates the rest.
From your first patient to your first publication.
Celéri's clinical infrastructure is designed to meet you where you are — whether you're starting a quality program, designing an investigator-initiated study, or contributing to a multicenter investigator-initiated study.
Deploy PainIntel
Celéri configures your Pain Pathway algorithm at kickoff — mapping your procedure types, appointment workflows, and PRO instruments. EHR integration covered at no cost to you. Zero ongoing staff burden.
Build Your Registry
Every patient, every encounter, every follow-up — captured automatically. Your longitudinal registry grows in the background while you practice. No paper forms. No research coordinator required. See your insights building in real time in your Pain Command Center.
Identify Your Research Question
When you're ready to go further, the Celéri Research Group helps you frame your study, select the right protocol track — Practice Insights Registry™ or Regulatory-Grade Evidence Cohort™ — and stand up the right partner team.
Publish
Medical writing, biostatistics, and IRB coordination are available through the Research Group. Your data was structured for publication from day one — so when you're ready to submit, the infrastructure is already in place.
Choose your research track.
Celéri supports two primary evidence pathways — each designed for a different research objective and regulatory context. Both run on the same PainIntel infrastructure your practice already uses.
Practice Insights Registry™
Observational, practice-level data collection designed to build structured outcomes evidence directly from your practice. Ideal for quality improvement, payer conversations, congress abstracts, and investigator-initiated publications.
- No pre-specified comparator required
- IRB-optional for quality programs
- Longitudinal PRO capture across your full patient population
- Benchmarking against Celéri's aggregate network data
- Abstract and publication-ready structured dataset
- Foundation for investigator-initiated study design
Regulatory-Grade Evidence Cohort™
Pre-specified protocol, IRB oversight, 21 CFR Part 11 data environment, and validated comparator logic — designed for data that needs to hold up to FDA, payer, and peer-review scrutiny. The right infrastructure for investigator-initiated trials and studies where data needs to hold up to peer-review, IRB, or regulatory scrutiny.
- Pre-specified protocol and statistical analysis plan
- IRB submission support through Celéri Research Group
- 21 CFR Part 11-compatible audit trail (via Greenlight Guru Clinical)
- Biostatistics and HEOR support available
- Supports investigator-initiated trials and multicenter study participation
- Medical writing and publication coordination included
Your outcomes data is already worth something.
Practices running PainIntel often discover they have a publication-ready dataset within 12–18 months of deployment — without ever running a formal study. A structured longitudinal registry is the foundation for payer conversations, credentialing, congress abstracts, and investigator-initiated research. Celéri's infrastructure ensures your data is structured for all of those purposes from day one.
Match your objective to the right track.
Not sure which pathway fits your goals? Here's how they map to common research objectives.
| Your Goal | Recommended Pathway | Key Infrastructure | Timeline to First Output |
|---|---|---|---|
| Gather patient-level PROs and intake data for use in medical decision-making | PainIntel™ Point of Care | PainIntel + Pain Command Center | 4–6 weeks to deployment |
| Build outcomes data for payer or credentialing conversations | Practice Insights Registry™ Quality Program | PainIntel + Command Center | 3–6 months of enrollment |
| Submit an abstract to NANS, ISMCS, ASRA, or ASPN | Practice Insights Registry™ Publication | PainIntel + Medical Writing | 12–18 months of enrollment |
| Publish in a peer-reviewed journal | Regulatory-Grade Evidence Cohort™ Publication | PainIntel + IRB + Biostatistics | 18–24 months from protocol approval |
| Join a sponsored multicenter registry (optional) | EaaS™ Sponsored Engagement | PainIntel + EaaS sponsor infrastructure | FMV compensation; enrollment-based |
| Run an investigator-initiated trial | Regulatory-Grade Evidence Cohort™ IIT | PainIntel + CRG full-service coordination | Varies by study design and IRB timeline |
| Run a multicenter investigator-initiated trial | Regulatory-Grade Evidence Cohort™ Multicenter IIT | GGG Clinical EDC + Hart CRO + Biostatistics | Scoped with Celéri Research Group |
You don't have to build a research team.
We've already built one.
The Celéri Research Group gives clinician-researchers access to best-in-class partners across every dimension of a study — without the overhead of managing multiple vendor relationships.
What clinician-researchers ask us most.
-
No. PainIntel is designed to run without research staff. Configuration happens once at kickoff — Celéri builds your Pain Pathway algorithm based on your procedure types. From there, PRO assessments are delivered automatically via SMS, email, or tablet, and data flows to your Command Center without staff intervention. For formal study activation, the Celéri Research Group provides coordination support through its partner network.
-
For an abstract submission (NANS, ISMCS, ASRA), most practices have sufficient data within 12–18 months of consistent enrollment. For a peer-reviewed manuscript, 18–24 months is typical depending on procedure volume and the study question. For practices joining a multicenter IIT, timelines depend on the lead investigator's study design and IRB approval process.
-
Yes. For practices moving from a quality program to a formal investigator-initiated study, the Celéri Research Group provides IRB submission support through Hart Clinical Consultants. Celéri also maintains master IRB protocols for certain study designs that can significantly accelerate local review timelines. For multicenter investigator-initiated trials, Celéri coordinates IRB submission across sites through the Research Group.
-
Yes, when applicable. Practices that participate in multicenter sponsored registries coordinated through Celéri receive fair market value compensation for data contribution, structured by the sponsoring organization. For investigator-initiated studies, compensation flows through the study's grant or funding mechanism. Your Practice Insights Registry™ data — collected as part of your standard PainIntel deployment — belongs to your practice and is not subject to any external compensation arrangement.
-
Yes — and Celéri covers all integration costs. Eight EHR systems are currently supported: Epic, Cerner, Athena, eClinics, DrChrono, Meditech, Veradigm, and Modernizing Medicine. Integration depth — not just connection — is what makes your registry meaningful and publication-ready, so Celéri treats it as a core part of the platform.
-
Celéri can evaluate historical data for inclusion depending on the format, completeness, and collection methodology. For most investigator-initiated studies, Celéri recommends establishing a clean baseline at PainIntel activation rather than attempting to normalize heterogeneous historical data — but existing data can often be used for power calculations and preliminary feasibility assessments.
Start building evidence from your practice today.
Whether you're beginning with a quality outcomes program or ready to design a formal investigator-initiated study — Celéri gives you the infrastructure to get there without leaving clinical practice.